Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rowbotham

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Pain|December 27, 2018
The IASP classification of chronic pain for ICD-11: chronic neuropathic painJoachim Scholz, Nanna B Finnerup, Nadine Attal, et al.
The Journal of Pain|March 4, 2017
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT ConsiderationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|September 12, 2021
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendationsBethea A Kleykamp, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|April 17, 2021
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendationsJennifer S Gewandter, Shannon M Smith, Robert H Dworkin, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Pain|December 27, 2018
The IASP classification of chronic pain for ICD-11: chronic neuropathic painJoachim Scholz, Nanna B Finnerup, Nadine Attal, et al.
The Journal of Pain|March 4, 2017
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT ConsiderationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|September 12, 2021
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendationsBethea A Kleykamp, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|April 17, 2021
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendationsJennifer S Gewandter, Shannon M Smith, Robert H Dworkin, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 15